ZIVO

$7.25-10.71%

Zivo Bioscience, Inc.

Market Cap

$28M

Live price × SEC shares (Nov 9, 2025)

Sector

Health Care

Industry

Biological Products, (No Diagnostic Substances)

Beta (raw)

0.33

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2025 · negative earnings

No 10-Q/10-K since Nov 14, 2025

P/S (TTM)

134.9

TTM to Sep 2025 · revenue

No 10-Q/10-K since Nov 14, 2025

P/B

N/M

TTM to Sep 2025 · negative equity

No 10-Q/10-K since Nov 14, 2025

EV/EBITDA (TTM)

—

EV / TTM EBITDA

No 10-Q/10-K since Nov 14, 2025

Loading…

Financial Statements

USD thousands	Q4 FY2024 Dec 31, 2024	Q1 FY2025 Mar 31, 2025	Q2 FY2025 Jun 30, 2025	Q3 FY2025 Sep 30, 2025	TTM Sep 30, 2025
Revenue	90	0	53	66	209
Cost of revenue	63	0	35	44	143
Gross profit	27.0	0.0	17.9	21.3	66.2
Research & development	243	2,769	480	203	3,696
Total operating expenses	1,623	4,209	1,651	1,040	8,523
Operating income	(1,596)	(4,209)	(1,633)	(1,018)	(8,456)
Interest expense		2.4	7.4	13.0
Net income	(1,601)	(4,211)	(1,640)	(1,033)	(8,486)
EPS (diluted) ($)		(1.12)	(0.43)	(0.27)	—
Weighted avg. shares (diluted)		3,750	3,810	3,817

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 14, 2025, period ended Sep 30, 2025. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 58 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Mar 30, 2026 accepted 8:01 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Dec 23, 2025 accepted 4:06 PM ET	5.02Officer / director change	Document SEC ↗
Sep 10, 2025 accepted 9:49 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 18, 2025 accepted 4:12 PM ET	5.02Officer / director change	Document SEC ↗
Jul 14, 2025 accepted 4:59 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Jun 11, 2025 accepted 4:10 PM ET	5.07Shareholder vote	Document SEC ↗
Jan 27, 2025 accepted 5:21 PM ET	3.02Unregistered equity sale	Document SEC ↗
Jan 15, 2025 accepted 5:14 PM ET	1.01Material agreement	Document SEC ↗
Jan 7, 2025 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
Nov 15, 2024 accepted 6:30 AM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-04-17	2026-04-24	STROME MARK E	10% Owner	Purchase	100.0K	$2.00	$200K	572.9K	View
2026-02-27	2026-03-03	YALDOO LAITH L	Director	Purchase	1,543	$9.72	$15K	583.6K	View
2026-02-12	2026-02-17	STROME MARK E	10% Owner	Purchase	20.0K	$9.77	$195K	472.9K	View
2026-02-10	2026-02-12	YALDOO LAITH L	Director	Purchase	2,434	$10.27	$25K	582.1K	View

Recent News

ZIVO 8-K & SEC Filings

Yahoo Finance Australia · 2026-11-01

ADC,ZIVO,CAG,LLY,PLAB,IAS,ANGO,MLSS,CBK,KFY | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada · 2026-10-31

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing

Yahoo Finance · 2026-06-26

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th

Yahoo Finance · 2026-06-23

Zivo Bioscience Inc (ZIVO) sentiment score, message volume, participation score and buzz level

Stocktwits · 2024-11-28

SMCI Stock Alert: Super Micro Computer Joins the S&P 500 Today

InvestorPlace · 2024-03-18

Zivo Bioscience Stock Price Forecast. Should You Buy ZIVO?

StockInvest.us · 2020-12-12

ZIVO Bioscience (OTCPK:ZIVO) - Stock Analysis

Simply Wall St · 2017-12-03

ZIVO Stock Price and Chart — OTC:ZIVO

TradingView · 2017-09-02

Informational purposes only, not investment advice.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Mar 30, 2026 accepted 8:01 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Dec 23, 2025 accepted 4:06 PM ET	5.02Officer / director change	Document SEC ↗
Sep 10, 2025 accepted 9:49 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 18, 2025 accepted 4:12 PM ET	5.02Officer / director change	Document SEC ↗
Jul 14, 2025 accepted 4:59 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Jun 11, 2025 accepted 4:10 PM ET	5.07Shareholder vote	Document SEC ↗
Jan 27, 2025 accepted 5:21 PM ET	3.02Unregistered equity sale	Document SEC ↗
Jan 15, 2025 accepted 5:14 PM ET	1.01Material agreement	Document SEC ↗
Jan 7, 2025 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
Nov 15, 2024 accepted 6:30 AM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗

ZIVO

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Zivo Bioscience, Inc. (ZIVO)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-04-17	STROME MARK E	P	100,000	$200,000
2026-02-27	YALDOO LAITH L	P	1,543	$14,997.96
2026-02-12	STROME MARK E	P	20,000	$195,400
2026-02-10	YALDOO LAITH L	P	2,434	$24,997.18